ArticleThe oncologist2022

"Game Changer": Health Professionals' Views on the Clinical Utility of Circulating Tumor DNA Testing in Hereditary Cancer Syndrome Management.

Salma Shickh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.